Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.

Article Details

Citation

Bymaster FP, Beedle EE, Findlay J, Gallagher PT, Krushinski JH, Mitchell S, Robertson DW, Thompson DC, Wallace L, Wong DT

Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.

Bioorg Med Chem Lett. 2003 Dec 15;13(24):4477-80.

PubMed ID
14643350 [ View in PubMed
]
Abstract

A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and norepinephrine reuptake. One member of this series, duloxetine (Cymbalta) has proven to be effective in clinical trials for the treatment of depression.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
DuloxetineSodium-dependent dopamine transporterKi (nM)240N/AN/ADetails
DuloxetineSodium-dependent noradrenaline transporterKi (nM)7.5N/AN/ADetails
DuloxetineSodium-dependent serotonin transporterKi (nM)0.8N/AN/ADetails